Effect of prime ultrafiltration on pro-calcitonin and respiratory function in the infants undergoing cardiopulmonary bypass
Phase 2
- Conditions
- infants required cardiac surgery with cardiopulmonary bypass pump (due to congenital anomalies).Other congenital malformations of heart
- Registration Number
- IRCT20180110038301N1
- Lead Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
pregnancy duration equal or more than 37 weeks
Parental consent
weight under 10 kg
open heart surgery
no other major congenital anomaly affected post-op recovery
No previous sternotomy
Exclusion Criteria
cardiac arrest during the operation
using defibrillator during the operation
aortic clamp time less than 30 minutes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean level of serum procalcitonin. Timepoint: first and 24 hour after admission to ICU. Method of measurement: Electro-chemiluminescence immunoassay (ECLIA) method via cobas, Roshe.;Respiratory Index. Timepoint: pre-operative after induction of anesthesia, at the end of operation and 2 hours after ICU admission. Method of measurement: Ventilator output.;Pulmonary compliance. Timepoint: pre-operative after induction of anesthesia, at the end of operation and 2 hours after ICU admission. Method of measurement: Ventilator output.
- Secondary Outcome Measures
Name Time Method